Vaccinia virus induces programmed necrosis in ovarian cancer cells

Lynsey M Whilding1, Kyra M Archibald, Hagen Kulbe

  • 1Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

Insights

Oncolytic vaccinia virus induces ovarian cancer cell death via programmed necrosis, not apoptosis or autophagy. This regulated cell death involves specific protein complexes and metabolic changes, offering new therapeutic insights.

Area of Science:

  • Oncology
  • Virology
  • Cell Biology

Background:

  • The precise mechanisms of oncolytic vaccinia virus-mediated tumor cell death remain unclear.
  • Understanding these pathways is crucial for optimizing oncolytic virotherapy efficacy.

Purpose of the Study:

  • To investigate the specific cell death pathways induced by vaccinia virus in ovarian cancer cells.
  • To differentiate between apoptosis, autophagy, and other cell death modalities.

Main Methods:

  • Infection of ovarian cancer cells with wild-type and dTK Lister strain vaccinia virus.
  • Analysis of cell death markers, including phosphatidylserine externalization, DNA content, LC3 lipidation, and transmission electron microscopy.
  • Assessment of intracellular ATP levels, mitochondrial metabolism, HMGB1 release, and protein complex formation (RIP1/caspase-8).
  • Pharmacological inhibition studies targeting RIP1, MLKL, and TNF-α signaling.

Main Results:

  • Vaccinia virus infection induced necrotic cell death, not classical apoptosis, despite some apoptotic features.
  • Autophagy was not generally activated, and cell death did not depend on autophagy induction.
  • Necrosis was characterized by reduced ATP, altered mitochondrial metabolism, HMGB1 release, and formation of a RIP1/caspase-8 complex.
  • Inhibition of RIP1 and MLKL significantly reduced cell death, while TNF-α blockade had no effect.

Conclusions:

  • Vaccinia virus induces programmed necrotic cell death in ovarian cancer cells.
  • This process is mediated by specific molecular players like RIP1 and does not rely on apoptosis or autophagy.
  • Findings provide insights into the regulated nature of oncolytic virus-induced cell death.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...